Pages that link to "Q54342471"

The following pages link to Treatment of advanced refractory ovarian carcinoma with a gonadotropin-releasing hormone analogue. (Q54342471):

Displaying 16 items.

• Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis (Q33779856) (← links)
• GnRH receptor and apoptotic signaling (Q33861087) (← links)
• Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone (Q35068355) (← links)
• Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75. (Q35614963) (← links)
• A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer (Q35993536) (← links)
• Peptide analogues alter the progression of premalignant lesions, as measured by Photofrin fluorescence (Q36138890) (← links)
• Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview. (Q37311391) (← links)
• Gonadotrophin-releasing hormone agonists. A guide to use and selection (Q40394336) (← links)
• Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders (Q40398462) (← links)
• Ovarian epithelial tumour in gonadal dysgenesis. A case report and literature review (Q41085757) (← links)
• Chemotherapy versus hormonal treatment in platinum- and paclitaxel-refractory ovarian cancer: a randomised trial of the German Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Ovarian Cancer (Q43910355) (← links)
• A phase II trial of D-Trp-6-LHRH (decapeptyl) in pretreated patients with advanced epithelial ovarian cancer (Q49327827) (← links)
• GnRH agonist analog therapy in advanced/recurrent granulosa cell tumors: further evidence of a role of inhibin in monitoring response to treatment. (Q54256048) (← links)
• Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group (Q71611166) (← links)
• Effect of a gonadotropin releasing hormone analog on an experimental ovarian tumor: Direct and indirect actions (Q71834179) (← links)
• Rational use of agonists and antagonists of luteinizing hormone-releasing hormone (LH-RH) in the treatment of hormone-sensitive neoplasms and gynaecologic conditions (Q73850253) (← links)